相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
The KRAS(G12C) Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin et al.
CANCER DISCOVERY (2020)
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
Jenny Y. Xue et al.
NATURE (2020)
Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
Panagiotis Sarantis et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2020)
Metabolic characterization of colorectal cancer cells harbouring different KRAS mutations in codon 12, 13, 61 and 146 using human SW48 isogenic cell lines
Dorna Varshavi et al.
METABOLOMICS (2020)
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
Josef Gillson et al.
CANCERS (2020)
Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation
Francesca Ricciardiello et al.
ONCOGENE (2020)
Overcoming Resistance to Drugs Targeting KRASG12C Mutation
Delong Jiao et al.
INNOVATION (2020)
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies
Kevin Lou et al.
SCIENCE SIGNALING (2019)
Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer
Neha M. Akella et al.
BMC BIOLOGY (2019)
Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Stefan Mereiter et al.
CANCER CELL (2019)
Drugging an undruggable pocket on KRAS
Dirk Kessler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
New therapeutic targets in pancreatic cancer
Eleonora Lai et al.
CANCER TREATMENT REVIEWS (2019)
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Andrew M. Waters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
2-Deoxy-D-glucose increases GFAT1 phosphorylation resulting in endoplasmic reticulum-related apoptosis via disruption of protein N-glycosylation in pancreatic cancer cells
Kousuke Ishino et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Protein N-glycosylation alteration and glycolysis inhibition both contribute to the antiproliferative action of 2-deoxyglucose in breast cancer cells
Audrey Berthe et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
Cecilia Lopez Sambrooks et al.
CANCER RESEARCH (2018)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Design, Synthesis, and Preliminary Biological Evaluation of GlcNAc-6P Analogues for the Modulation of Phosphoacetylglucosamine Mutase 1 (AGM1/PGM3)
Alice Paiotta et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2018)
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis
Francesca Ricciardiello et al.
CELL DEATH & DISEASE (2018)
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Ferdinando Chiaradonna et al.
CELLS (2018)
Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
Naiara Santana-Codina et al.
NATURE COMMUNICATIONS (2018)
Targeting metabolic reprogramming in KRAS-driven cancers
Kenji Kawada et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2017)
Survival of pancreatic cancer cells lacking KRAS function
Mandar Deepak Muzumdar et al.
NATURE COMMUNICATIONS (2017)
RPN2 promotes colorectal cancer cell proliferation through modulating the glycosylation status of EGFR
Haiping Li et al.
ONCOTARGET (2017)
Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
Ru Chen et al.
SCIENTIFIC REPORTS (2017)
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
Nirakar Rajbhandari et al.
CELL REPORTS (2017)
Profiling of different pancreatic cancer cells used as models for metastatic behaviour shows large variation in their N-glycosylation
Stephanie Holst et al.
SCIENTIFIC REPORTS (2017)
Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras
Tim Wang et al.
CELL (2017)
Genetics and biology of pancreatic ductal adenocarcinoma
Haoqiang Ying et al.
GENES & DEVELOPMENT (2016)
Cyclin D1, cancer progression, and opportunities in cancer treatment
Shuo Qie et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism
Piro Lito et al.
SCIENCE (2016)
Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State
Matthew P. Patricelli et al.
CANCER DISCOVERY (2016)
Protein Kinase A Activation Promotes Cancer Cell Resistance to Glucose Starvation and Anoikis
Roberta Palorini et al.
PLOS GENETICS (2016)
Fundamentals of cancer metabolism
Ralph J. DeBerardinis et al.
SCIENCE ADVANCES (2016)
Nutrient shortage triggers the hexosamine biosynthetic pathway via the GCN2-ATF4 signalling pathway
Cedric Chaveroux et al.
SCIENTIFIC REPORTS (2016)
Metabolic Dependencies in RAS-Driven Cancers
Alec C. Kimmelman
CLINICAL CANCER RESEARCH (2015)
N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes
Karol Kaszuba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
Anneleen Daemen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines
Britta Stolze et al.
SCIENTIFIC REPORTS (2015)
Glycosylation in cancer: mechanisms and clinical implications
Salome S. Pinho et al.
NATURE REVIEWS CANCER (2015)
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Lola Rahib et al.
CANCER RESEARCH (2014)
KRAS and YAP1 Converge to Regulate EMT and Tumor Survival
Diane D. Shao et al.
CELL (2014)
Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells
Zhiyuan Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Oncogenic K-ras expression is associated with derangement of the cAMP/PKA pathway and forskolin-reversible alterations of mitochondrial dynamics and respiration
R. Palorini et al.
ONCOGENE (2013)
Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
Fabienne Guillaumond et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Glucose starvation induces cell death in K-ras-transformed cells by interfering with the hexosamine biosynthesis pathway and activating the unfolded protein response
R. Palorini et al.
CELL DEATH & DISEASE (2013)
O-GlcNAcylation: a new cancer hallmark?
Yann Fardini et al.
FRONTIERS IN ENDOCRINOLOGY (2013)
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
Haoqiang Ying et al.
CELL (2012)
Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth
Daniela Gaglio et al.
MOLECULAR SYSTEMS BIOLOGY (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Mitochondrial Complex I decrease is responsible for bioenergetic dysfunction in K-ras transformed cells
Alessandra Baracca et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2010)
A Gene Expression Signature Associated with K-Ras Addiction Reveals Regulators of EMT and Tumor Cell Survival
Anurag Singh et al.
CANCER CELL (2009)
Glutamine Deprivation Induces Abortive S-Phase Rescued by Deoxyribonucleotides in K-Ras Transformed Fibroblasts
Daniela Gaglio et al.
PLOS ONE (2009)
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
Joseph N. Contessa et al.
CANCER RESEARCH (2008)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
Expression of transforming K-Ras oncogene affects mitochondrial function and morphology in mouse fibroblasts
Ferdinando Chiaradonna et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Ras-dependent carbon metabolism and transformation in mouse broblasts
F. Chiaradonna et al.
ONCOGENE (2006)
UDP-GlcNAc concentration is an important factor in the biosynthesis of β1,6-branched oligosaccharides:: regulation based on the kinetic properties of N-acetylglucosaminyltransferase V
K Sasai et al.
GLYCOBIOLOGY (2002)
A dominant negative RAS-specific guanine nucleotide exchange factor reverses neoplastic phenotype in K-ras transformed mouse fibroblasts
P Bossù et al.
ONCOGENE (2000)
分享论文
